Essay
Published essay on founder-led investing in life sciences, emphasizing the importance of founders who design initial conditions of their companies.
Founder-driven life sciences companies
Added recently
Investment
Participated in Stately Bio's $12M Seed round, a cell therapy company using ML-powered live-cell imaging.
Stately Bio
MAY 2, 2025
Investment
Participated in BigHat Biosciences' Series B-II round, an AI-driven antibody design platform company.
BigHat Biosciences
APR 17, 2025
Investment
Participated in Stately Bio's $12M seed round for regenerative medicine development using machine learning-driven cell imaging.
Stately Bio
APR 2025